Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Saliva Or Blood Samples

Research Leaders

13 sponsors active, led by Susan G. Komen Breast Cancer Foundation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00579618CompletedPrimary

Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging

Showing all 1 trials

Research Network

Common Treatments

  • Saliva Or Blood Samples1

Active Sponsors

  • Susan G. Komen Breast Cancer Foundation1
  • Parker Jewish Institute1
  • Lenox Hill Neighborhood House1
  • Van Cortlandt Village Senior Center1
  • Northern Services Group1

Top Investigators

Activity Timeline